Weber Capital Management’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
SFM
AC
RA
BH
Weber Capital Management's ANGO Position: Q2 2026 in Review
Weber Capital Management reduced its AngioDynamics (ANGO) stake by 1.2% in Q2 2026, selling an estimated $188K and leaving 1,356,602 shares worth $17.6M. The position accounts for 15.02% of the portfolio, ranked #4.
Weber Capital Management first reported a position in ANGO in Q4 2025 and has held it in 3 quarters since. The position peaked at $18M in Q4 2025. 162 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.
- Weber Capital Management held 1,356,602 shares of AngioDynamics worth $17.6M as of Q2 2026.
- Weber Capital Management sold 16,547 AngioDynamics shares in Q2 2026, an estimated $188K.
- AngioDynamics made up 15.02% of Weber Capital Management's portfolio in Q2 2026, its #4 holding.
- Weber Capital Management first reported a position in AngioDynamics in Q4 2025 and has held it in 3 quarters since.
- Weber Capital Management's AngioDynamics position peaked at $18M in Q4 2025.
- 162 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.
Based on Weber Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.